Purdue pharma brings restructuring expert aboard: 6 things to know – Becker’s Hospital Review

Written by Alia Paavola | July 24, 2018 | Print  | Email Embattled OxyContin maker Purdue Pharma hired Steve Miller, a famous figure in corporate restructuring, to head its board as the drugmaker seeks to overhaul its business and distance itself from the U.S. opioid crisis, Bloomberg reports. Here are six things to know: 1. Miller became…

FTD Companies, Inc. Announces Review of Strategic Alternatives, Corporate Restructuring and Cost Savings Plan and … – GlobeNewswire (press release)

Scott D. Levin Appointed Interim President and Chief Executive Officer Company Provides Update on 2018 Business Outlook DOWNERS GROVE, Ill., July 19, 2018 (GLOBE NEWSWIRE) —  FTD Companies, Inc. (Nasdaq:FTD) (FTD or the Company), a premier floral and gifting company, today announced that its Board of Directors has initiated a review of strategic alternatives focused…

FTD Companies, Inc. Announces Review of Strategic Alternatives, Corporate Restructuring and Cost Savings Plan and … – Markets Insider

Scott D. Levin Appointed Interim President and Chief Executive Officer Company Provides Update on 2018 Business Outlook DOWNERS GROVE, Ill., July 19, 2018 (GLOBE NEWSWIRE) —  FTD Companies, Inc. (Nasdaq:FTD) (FTD or the Company), a premier floral and gifting company, today announced that its Board of Directors has initiated a review of strategic alternatives focused…

Nexgram embarks on internal restructuring to streamline businesses – The Edge Markets MY

KUALA LUMPUR (July 19): Nexgram Holdings Bhd has embarked upon an internal corporate restructuring (ICR) of its wholly-owned subsidiary Nexgram Land Sdn Bhd and its group of companies to enable a more efficient administration of the organisation. Nexgram said the restructuring involves segregating the business segments of the group into the respective subsidiaries carrying out…

Does the Pfizer Restructuring Make Sense? – Pharmaceutical Executive (press release) (blog)

The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer. Pfizer recently announced a major restructuring into three business segments. The move followed an unsuccessful attempt by the company to market its OTC, or Consumer Healthcare segment as it will be…

Did hushed takeover planning allow BWX execs to buy cheap shares? – The Australian Financial Review

Say what you will about Waterloo Capital’s case against BWX BWX’s independent board committee says it’s “filed opportunistically” but no one really cares about whether Michael Fabregas is owed millions for allegedly being cut out of a management buyout deal he helped create. The interest and maybe this is Fabregas’ legal strategy is entirely in…